Table 1.
Clinical and metabolic characteristics of patients with PCOS and controls.
Table 2.
Univariate and multivariate logistic regression analyses of factors associated with steatosis (HSI>36) in the entire population of PCOS and controls.
Fig 1.
Prevalence of steatosis—defined as hepatic steatosis index > 36—according to presence of polycystic ovary syndrome (PCOS) and/or abdominal obesity.
Table 3.
Multivariate logistic regression analyses of factors associated with steatosis (HSI>36) in the entire population of PCOS, and in sub-groups according to presence/absence of abdominal obesity.
Table 4.
Multivariate linear regression analyses of factors associated with FIB-4 in the entire population of PCOS, and in sub-groups according to presence/absence of abdominal obesity.